The BCR-ABL fusion gene, which is created through chromosomes 9 and 22 translocation (also called Philadelphia chromosome), is a key oncogene in chronic myeloid leukemia (CML) [9–11]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.